Health Canada Approves AGAMREE® (vamorolone) as the First Treatment for Duchenne Muscular Dystrophy in Canada

MISSISSAUGA, ON, Oct. 2, 2025 /CNW/ - Kye Pharmaceuticals ("Kye") announced today that Health Canada has approved AGAMREE® (vamorolone) for the treatment of Duchenne Muscular Dystrophy (DMD) in boys a ...
TMCnet

Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic ...

Dyne will also present encore data on zeleciment rostudirsen (z-rostudirsen, formerly known as DYNE-251, aninvestigational medicine being evaluated for the treatment of individuals with DMD mutations ...
CBS Texas on MSN

North Texas boy doesn't let life-changing muscular dystrophy diagnosis stop him

AI-generated actor "Tilly Norwood" sparks outrage in Hollywood Cold weather warnings expand to 9 states as temperatures drop ...

Cerebellum found to contribute to symptoms in spinal muscular atrophy

Spinal muscular atrophy affects all the body's muscles. For a long time, it was considered a disease caused solely by the ...

Sickly Dogs: These are the 10 breeds of adorable dog tragically predisposed most health problems - including the loving Toy Poodle🐕

These pups can all make wonderful family pets, but they have medical issues that owners need to be aware of before welcoming ...
Healio

Ace the Case: A 68-Year-Old Woman With Early Symptoms of Geographic Atrophy

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].